Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945341680> ?p ?o ?g. }
Showing items 1 to 25 of
25
with 100 items per page.
- W2945341680 abstract "The FDA has approved brigatinib (Alunbrig) for the treatment of metastatic ALK-positive non-small-cell lung cancer, specifically in patients who have progressed on or are intolerant to crizotinib." @default.
- W2945341680 created "2019-05-29" @default.
- W2945341680 creator A5012027631 @default.
- W2945341680 date "2017-04-29" @default.
- W2945341680 modified "2023-09-23" @default.
- W2945341680 title "FDA Approves Brigatinib for Lung Cancer" @default.
- W2945341680 hasPublicationYear "2017" @default.
- W2945341680 type Work @default.
- W2945341680 sameAs 2945341680 @default.
- W2945341680 citedByCount "0" @default.
- W2945341680 crossrefType "journal-article" @default.
- W2945341680 hasAuthorship W2945341680A5012027631 @default.
- W2945341680 hasConcept C143998085 @default.
- W2945341680 hasConcept C2776256026 @default.
- W2945341680 hasConcept C71924100 @default.
- W2945341680 hasConceptScore W2945341680C143998085 @default.
- W2945341680 hasConceptScore W2945341680C2776256026 @default.
- W2945341680 hasConceptScore W2945341680C71924100 @default.
- W2945341680 hasLocation W29453416801 @default.
- W2945341680 hasOpenAccess W2945341680 @default.
- W2945341680 hasPrimaryLocation W29453416801 @default.
- W2945341680 isParatext "false" @default.
- W2945341680 isRetracted "false" @default.
- W2945341680 magId "2945341680" @default.
- W2945341680 workType "article" @default.